These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Willner DL; Hugenholtz P; Yerkovich ST; Tan ME; Daly JN; Lachner N; Hopkins PM; Chambers DC Am J Respir Crit Care Med; 2013 Mar; 187(6):640-7. PubMed ID: 23328523 [TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans: pathogenesis, prevention, and management. Paradis I Am J Med Sci; 1998 Mar; 315(3):161-78. PubMed ID: 9519929 [TBL] [Abstract][Full Text] [Related]
9. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection. Chen F; Miyagawa-Hayashino A; Yurugi K; Chibana N; Yamada T; Sato M; Aoyama A; Takakura S; Bando T; Date H Transpl Int; 2014 Feb; 27(2):e8-12. PubMed ID: 24164400 [TBL] [Abstract][Full Text] [Related]
10. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618 [TBL] [Abstract][Full Text] [Related]
11. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation. Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection. Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998 [TBL] [Abstract][Full Text] [Related]
13. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Charlson ES; Diamond JM; Bittinger K; Fitzgerald AS; Yadav A; Haas AR; Bushman FD; Collman RG Am J Respir Crit Care Med; 2012 Sep; 186(6):536-45. PubMed ID: 22798321 [TBL] [Abstract][Full Text] [Related]
14. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients. Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation. Hachem R; Corris P Transplantation; 2018 Jul; 102(7):1059-1065. PubMed ID: 29557913 [TBL] [Abstract][Full Text] [Related]
19. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation. Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692 [TBL] [Abstract][Full Text] [Related]
20. Are we near to an effective drug treatment for bronchiolitis obliterans? Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]